Why the study?
In people who inject drugs, right-sided infective endocarditis often presents as septic pulmonary embolism and can be easily misdiagnosed as pulmonary embolism, pneumonia, or primary cardiomyopathy, delaying specific treatment.
Case Report (n=1)
Yes
Answers are grounded in this paper and cite their sources.
Right-sided infective endocarditis can mimic pulmonary thromboembolism and primary dilated cardiomyopathy in patients with a history of injection drug use, and associated severe left ventricular systolic dysfunction may be reversible, supporting surgical valve replacement when conservative therapy fails.
Introduction. In people who inject drugs, infective endocarditis primarily affects the right side of the heart and often presents as septic pulmonary embolism. This clinical presentation can be easily misdiagnosed as pulmonary embolism, pneumonia, or primary cardiomyopathy, leading to delays in specific treatment. Case Description. A 50-year-old man who had been enrolled in a methadone maintenance program for four years was hospitalized with dyspnea at rest, orthopnea, fever, and lower-extremity edema; his oxygen saturation on room air was 85%. Echocardiography revealed dilation of all cardiac chambers, an ejection fraction of 18–20%, a pulmonary artery systolic pressure of 90 mmHg, and two mobile masses (17×8 mm and 17×7 mm) on the tricuspid valve leaflets. D-dimer levels exceeded 4000 ng/mL, and computed tomography angiography revealed bilateral segmental filling defects against a background of cavitating nodular lesions; the veins of the lower extremities were fully compressible. Antibiotic therapy remained empirical throughout, with the regimen changed three times. Despite 16 days of conservative treatment, fever, vegetations, and elevated inflammatory markers persisted, prompting the patient's transfer to a specialized clinic. There, preoperative echocardiography showed that the ejection fraction had already improved to 52%; coronary angiography ruled out hemodynamically significant coronary artery disease, and the tricuspid valve was replaced with a biological prosthesis. The patient was discharged in improved condition, and nine months later, heart failure corresponded to Functional Class II. Conclusion. Right-sided infective endocarditis should be considered in the differential diagnosis of any patient with a history of injection drug use, fever, and multiple focal pulmonary lesions-even when computed tomography shows filling defects in the pulmonary artery. Severe systolic dysfunction in these patients may be partially reversible and should not, in itself, be a reason to decline surgical intervention.
No takes yet. Share an insight, caveat, or question.
LEKVEISHVILI et al. (2026) conducted a case report in Right-sided infective endocarditis with septic pulmonary embolism and severe systolic heart failure (n=1). Tricuspid valve replacement with a biological prosthesis following empirical antibiotic and heart failure therapy was evaluated on Clinical recovery, left ventricular ejection fraction improvement, and NYHA functional class at 9 months.
Synapse has enriched 10 related papers. Consider them for comparative context: